Abstract

Simultaneous determination of ezetimibe and atorvastatin calcium in spiked human plasma using SPE coupled to HPLC-MS/MS

Author(s): Yehia Z.Baghdady, Medhat A.Al-Ghobashy, Abdel-Aziz E.Abdel-Aleem, Soheir A.Weshahy

Combination drug products containing ezetimibe (EZB) and atorvastatin calcium (ATVC) are widely used for treatment of hyperlipidemia.Arapid, simple and sensitive liquid chromatography–tandem mass spectrometry (LC-MS/MS)method for determination of EZB andATVC in spiked human plasma has been developed and validated.Plasma samples were subjected to solid phase extraction before analysis with an extraction recovery of 90.59 - 98.02%. Chromatographic separation was performed on a C18 column using isocratic elutionwithin 2 min run time. The mobile phase consisted of acetonitrile: 1%of formic acid inwater (8: 2, v/v) and was pumped at a flow rate of 0.8 mL/min. Detection of analytes was achieved by with electrospray ionization (ESI) in negative ionmode for EZB and positive ion mode forATVC. The calibration curves were linear over the range of 1.67 – 83.33 ng/mL for both drugs. The precision at the lower limit of quantitation for EZB (12.97%) andATVC (8.99%) was determined. The intra- and interday precisionswere within 9.16%, while the accuracy ranged from94.18 to 106.94%. The validated LC-MS/MSmethod was successfully employed for thedetermination of EZB andATVC in spiked human plasma for application in therapeutic drugmonitoring.


Share this       

Share this Page.

Table of Contents

Flyer
izmir escort izmir escort bursa escort antalya escort izmir escort porno porno izle türk porno eskişehir escort bartın escort burdur escort izmir escort bursa escort porno indir izle istanbul escort istanbul escort bayan escort izmir